Tensha Therapeutics

Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders.

Business Model:

Revenue: $0

Employees: 2-10

Rankings

Detailed Tensha Therapeutics Information

Tensha Therapeutics was acquired by Roche.
The acquisition happend on 2016-01-11.
Details of the transaction were not public

Acquirer

Geographic Data

Tensha Therapeutics headquarters map

Address: 55 Cambridge Pkwy

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

undisclosed

Raised Last:

$0

Raised Total:

$15M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Tensha Therapeutics develops small molecule bromodomain inhibitors to treat cancer and other serious disorders.

Contact Phone:
+16172524343

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2012 Funding Round 1 - Torrey Pines Investment
Torrey Pines Investment
9/2011 Series A 1 $15M HealthCare Ventures
HealthCare Ventures
HealthCare Ventures
HealthCare Ventures
7/2011 Equity $500k HealthCare Ventures
4/2012 Funding Round 1 - Torrey Pines Investment
Torrey Pines Investment
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research